dronabinol has been researched along with Acanthamoeba Meningoencephalitis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bradley, SG; Cabral, G; Ferguson, T; Marciano-Cabral, F | 1 |
1 other study(ies) available for dronabinol and Acanthamoeba Meningoencephalitis
Article | Year |
---|---|
Delta-9-tetrahydrocannabinol (THC), the major psychoactive component of marijuana, exacerbates brain infection by Acanthamoeba.
Topics: Acanthamoeba; Amebiasis; Animals; Antibodies, Protozoan; Brain Diseases; Central Nervous System Protozoal Infections; Cyclophosphamide; Disease Models, Animal; Dronabinol; Female; Humans; Immunocompetence; Immunocompromised Host; Immunosuppressive Agents; Mice | 2001 |